CEA-CD3 bispecific antibody cibisatamab with or without atezolizumab in patients with CEA-positive solid tumours: results of two multi-institutional Phase 1 trials
CEA-CD3双特异性抗体cibisatamab联合或不联合atezolizumab治疗CEA阳性实体瘤患者:两项多中心I期试验的结果
期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-024-48479-8
Segal, Neil H; Melero, Ignacio; Moreno, Victor; Steeghs, Neeltje; Marabelle, Aurelien; Rohrberg, Kristoffer; Rodriguez-Ruiz, Maria E; Eder, Joseph P; Eng, Cathy; Manji, Gulam A; Waterkamp, Daniel; Leutgeb, Barbara; Bouseida, Said; Flinn, Nick; Das Thakur, Meghna; Elze, Markus C; Koeppen, Hartmut; Jamois, Candice; Martin-Facklam, Meret; Lieu, Christopher H; Calvo, Emiliano; Paz-Ares, Luis; Tabernero, Josep; Argilés, Guillem